Fast-spreading SARS-CoV-2 Variant in the U.K. Raises More QuestionsJanuary 6, 2021
The U.K. strain of COVID-19 virus maybe 70% more transmissible than the previously reported types, though no enough evidence yet if it is more deadly. This led UK Prime Minster Boris Johnson to place tighter COVID-19 restrictions in London and southeastern England to contain the fast-spreading virus.
In early December 2020, a group of UK scientists gathered virtually to report the spread of pandemic coronavirus. Their discussions funneled into the increasing cases in Kent, a county in southeastern England, while the rest of the country was managing the spread of the virus. This led to investigations of viral genomes from the region, which showed that half of the cases in Kent were caused by a variant labeled as B.1.1.7, which is more skillful in transmitting between humans.
Aside from its ability to spread faster, the variant was found to have a mutation that leads to the loss of two amino acids in the spike protein. When virologist Ravindra Gupta from the University of Cambridge engineered a lentivirus to express the mutated versions of SARS-CoV-2's spike, it was found that the deletion alone made the virus twice as infectious for human cells.
These new findings raise more questions especially about the efficacy of the approved vaccines. Researchers are discussing if periodic updating of the vaccines might be necessary to effectively block the spread of the fast-evolving virus.
Read the original article in Science.
You might also like:
- WHO Calls for Actions to Encourage Acceptance and Uptake of COVID-19 Vaccines
- Study Identifies "Mother" of all SARS-CoV-2 Genomes; Reveals Earlier COVID-19 Timeline
- ISAAA COVID-19 Resource
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- ISAAA Presents 2019 Biotech Adoption Findings to Stakeholders in Europe and South America
- UBIC Builds NARO Anti-tick Vaccine Team's Capacity for Biosafety Compliance
- CIMMYT Announces Fall Armyworm Tolerant Maize Hybrids for Africa
- Researchers Find Flag Leaves Top Off Rice Photosynthetic Performance
- USDA APHIS Deregulates GE Corn with Enhanced Yield and Herbicide Tolerance Traits
- Price, Nutrition Among Top Factors that Affect Canadian Consumers' Choice to Buy GM Foods
- Scientists Boost Vegetable Oil Production in Plant Leaves
- CSIRO "Gene Sandwich" to Boost Wheat Resistance to Rust
- Bt Cotton Key in Eradicating Destructive Pest from the US and Mexico
- Target-AID and CRISPR-Cas9 Improve Lycopene Content in Tomatoes
- What are TALENs?
- Fast-spreading SARS-CoV-2 Variant in the U.K. Raises More Questions
Read the latest:
- Biotech Updates (February 1, 2023)
- Genome Editing Supplement (January 18, 2023)
- Gene Drive Supplement (January 25, 2023)
Subscribe to BU: